Angelyn Rios
- Immunology top 10%
- Molecular Biology
- Biotechnology top 5%
- Oncology
- Genetics
- Co-authors
- Richard L. SimmonsPrasanta K. RayG LundgrenCharles F. McKhannSimmons RlJohn H. KerseyDavid SteinmullerLuis H. Toledo‐Pereyra
- Topics
- Cancer Research and Treatments (12 papers)Virus-based gene therapy research (6 papers)Aquaculture disease management and microbiota (4 papers)
- Cited by
- BiotechnologyImmunologyEndocrinology
- Partner nations
- United States
In The Last Decade
Angelyn Rios
24 papers receiving 466 citations
Peers
Comparison fields: 5 of 66
- Immunology 320
- Molecular Biology 231
- Biotechnology 163
- Oncology 120
- Genetics 85
Countries citing papers authored by Angelyn Rios
This map shows the geographic impact of Angelyn Rios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelyn Rios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelyn Rios more than expected).
Fields of papers citing papers by Angelyn Rios
This network shows the impact of papers produced by Angelyn Rios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelyn Rios. The network helps show where Angelyn Rios may publish in the future.
Co-authorship network of co-authors of Angelyn Rios
This figure shows the co-authorship network connecting the top 25 collaborators of Angelyn Rios. A scholar is included among the top collaborators of Angelyn Rios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelyn Rios. Angelyn Rios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | In vitro susceptibility to fluconazole of Candida spp. isolates comparing three different methods | 11 |
| 2 | 1 | |
| 3 | Response of malignant melanoma to plasma exchange, surgical debulking, and Corynebacterium parvum. | 2 |
| 4 | 10 | |
| 5 | 8 | |
| 6 | Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine. | 5 |
| 7 | 34 | |
| 8 | 28 | |
| 9 | 15 | |
| 10 | Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells. | 31 |
| 11 | Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice. | 21 |
| 12 | 14 | |
| 13 | Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. II. Intratumor injections of neuraminidase. | 17 |
| 14 | 39 | |
| 15 | 21 | |
| 16 | 40 | |
| 17 | 39 | |
| 18 | 46 | |
| 19 | 96 | |
| 20 | Immunosuppressive effects of macrophage lysis. | 3 |
About Angelyn Rios
Angelyn Rios is a scholar working on Biotechnology, Immunology and Microbiology, having authored 24 papers that have together received 580 indexed citations. Recurring topics across this work include Cancer Research and Treatments (12 papers), Virus-based gene therapy research (6 papers) and Aquaculture disease management and microbiota (4 papers). The work is most often cited by research in Biotechnology (163 citations), Immunology (320 citations) and Endocrinology (34 citations). Angelyn Rios has collaborated with scholars based in United States. Frequent co-authors include Richard L. Simmons, Prasanta K. Ray, G Lundgren, Charles F. McKhann, Simmons Rl, Richard L. Simmons, Simmons Rl, John H. Kersey, David Steinmuller and Luis H. Toledo‐Pereyra. Their work appears in journals such as Science, The Journal of Immunology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.